Thank you, Madam Chair. As I indicated, in the Canadian Blood Service and the cost, the cost of blood and plasma protein
products is very volatile, so this huge shift is just a matter of two clients only. I think that initially when we were budgeting this, there was one client receiving some blood services. There are a lot of clients receiving blood services, but with this particular plasma protein there is one client receiving it. We got an additional two clients and then the amount went up immensely at that point.
This is something that would be hard to budget. This product keeps the people alive, Madam Chair. They have no option but to continue to receive this product from the Canadian Blood Service or the patients receiving this service would not be able to survive.